Rockefeller Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,581
| Closed | -$97K | – | 2922 |
|
|
2022
Q4 | $97K | Hold |
2,581
| – | – | ﹤0.01% | 2038 |
|
|
2022
Q3 | $114K | Sell |
2,581
-7,270
| -74% | -$321K | ﹤0.01% | 1923 |
|
|
2022
Q2 | $363K | Sell |
9,851
-1,405
| -12% | -$51.8K | ﹤0.01% | 1389 |
|
|
2022
Q1 | $416K | Sell |
11,256
-836
| -7% | -$30.9K | ﹤0.01% | 1390 |
|
|
2021
Q4 | $366K | Sell |
12,092
-1,320,688
| -99% | -$40M | ﹤0.01% | 1427 |
|
|
2021
Q3 | $44.7M | Buy |
1,332,780
+8,169
| +0.6% | +$274K | 0.23% | 101 |
|
|
2021
Q2 | $52.8M | Buy |
1,324,611
+590,632
| +80% | +$23.6M | 0.3% | 77 |
|
|
2021
Q1 | $33M | Buy |
733,979
+179,807
| +32% | +$8.08M | 0.22% | 105 |
|
|
2020
Q4 | $31.3M | Sell |
554,172
-162,953
| -23% | -$9.21M | 0.24% | 107 |
|
|
2020
Q3 | $34M | Buy |
717,125
+1,245
| +0.2% | +$59.1K | 0.32% | 72 |
|
|
2020
Q2 | $42.2M | Buy |
715,880
+45,742
| +7% | +$2.7M | 0.44% | 47 |
|
|
2020
Q1 | $31.7M | Buy |
670,138
+180,487
| +37% | +$8.53M | 0.42% | 46 |
|
|
2019
Q4 | $29.6M | Buy |
489,651
+485,973
| +13,213% | +$29.4M | 0.37% | 59 |
|
|
2019
Q3 | $220K | Sell |
3,678
-865
| -19% | -$51.7K | ﹤0.01% | 614 |
|
|
2019
Q2 | $292K | Sell |
4,543
-3,034
| -40% | -$195K | ﹤0.01% | 521 |
|
|
2019
Q1 | $615K | Buy |
7,577
+3,824
| +102% | +$310K | 0.01% | 448 |
|
|
2018
Q4 | $203K | Hold |
3,753
| – | – | ﹤0.01% | 401 |
|
|
2018
Q3 | $194K | Hold |
3,753
| – | – | ﹤0.01% | 350 |
|
|
2018
Q2 | $156K | Buy |
+3,753
| New | +$156K | ﹤0.01% | 352 |
|